NASH, Fatty Liver, Cirrhosis

Clinical Trial Info

  • Category

    Current Enrolling Clinical Trials

Non Alcoholic Steatohepatitis (NASH) is a type of fatty liver disease, characterized by inflammation of the liver with concurrent fat accumulation in liver.

NASH is closely related to the triple epidemic of obesity, pre-diabetes, and diabetes.  If you are living with NASH you may qualify for a clinical research study.  

Join Encore Borland Groover Clinical Research (EBGCR) for a complimentary Fibroscan test for fatty liver. 

ClinicalTrials.gov Study Details
Liver-biopsy Proven NASH
A phase 2b randomized, double blind, placebo-controlled, multicenter study evaluating safety and efficacy of EDP-305 in subjects with liver-biopsy proven non-alcoholic steatohepatitis (NASH) (ARGON-2)

Contact Research
Photo of Ana Corregidor MD
Gastroenterologist Encore Borland Groover Clinical Research
Clinical Research Location 4800 Belfort Road Jacksonville FL 32256 Contact Research: (904) 680-0871
Return to top.
Photo of Michael Herman M.D.
Gastroenterologist Fleming Island Center for Clinical Research
Clinical Research Location 1679 Eagle Harbor Parkway Suite D Fleming Island FL 32003 Contact Research: (904) 621-0390
Return to top.
Photo of Linda Di Teodoro M.D.
Encore Borland Groover Clinical Research
Clinical Research Location 4800 Belfort Road Jacksonville FL 32003 Contact Research: 904-680-0871
Return to top.